Cambrex Completes Biopharmaceutical Expansion at its Durham, NC Facility
April 07, 2020 08:45 ET
|
Cambrex Corporation
EAST RUTHERFORD, N.J., April 07, 2020 (GLOBE NEWSWIRE) -- Cambrex, the leading small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle,...
Cambrex Appoints Troy Player as President, Early Stage Development & Testing Business Unit
March 31, 2020 08:00 ET
|
Cambrex Corporation
EAST RUTHERFORD, N.J., March 31, 2020 (GLOBE NEWSWIRE) -- Cambrex, the leading small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle,...
Cambrex Announces Management Changes and Board Appointments
January 06, 2020 11:36 ET
|
Cambrex Corporation
EAST RUTHERFORD, N.J., Jan. 06, 2020 (GLOBE NEWSWIRE) -- Cambrex Corporation, the leading small molecule company providing drug substance, drug product and analytical services across the entire drug...
Cambrex Announces Completion of Acquisition by the Permira Funds
December 04, 2019 09:27 ET
|
Cambrex Corporation
EAST RUTHERFORD, N.J., Dec. 04, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the...
Cambrex Wins Third API Development Award at CPhI Worldwide
November 14, 2019 07:30 ET
|
Cambrex Corporation
EAST RUTHERFORD, N.J., Nov. 14, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the...
Cambrex Releases Selected Preliminary Third Quarter 2019 Financial Results
October 24, 2019 06:40 ET
|
Cambrex Corporation
EAST RUTHERFORD, N.J., Oct. 24, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the...
Cambrex Corporation Announces Expiration of “Go Shop” Period Under Merger Agreement
September 23, 2019 06:40 ET
|
Cambrex Corporation
EAST RUTHERFORD, N.J., Sept. 23, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM) (the “Company” or “Cambrex”) today announced the expiration, as of 12:01 a.m., Eastern Time, on September...
Cambrex Cancels Second Quarter Earnings Conference Call and Will Not Update Financial Guidance
August 07, 2019 12:55 ET
|
Cambrex Corporation
EAST RUTHERFORD, N.J., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the...
Cambrex to be Acquired by the Permira Funds for $60.00 per Share in Cash
August 07, 2019 06:30 ET
|
Cambrex Corporation
EAST RUTHERFORD, N.J., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the...
Cambrex to Announce Second Quarter 2019 Financial Results on August 9, 2019
August 06, 2019 10:10 ET
|
Cambrex Corporation
EAST RUTHERFORD, N.J., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the...